In this case, the KMT2A-AFF1 fusion and all somatic gene mutations present in the relapse ALL sample were shared in the AML sample, but the AML sample had also acquired several new genetic alterations, some in genes more commonly mutated in myeloid diseases (e.g., TET1 and TET2). The gene discussed is TET1; the disease is acute lymphoblastic leukemia.